Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|1|32-41

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.1, 2008-01, pp. : 32-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peripheral tachykinin receptors as targets for new drugs

By Patacchini R.   Maggi C.A.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Orphan Nuclear Receptors as Targets for Drug Development

By Mukherjee Subhajit   Mani Sridhar  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1439-1468

Springer Publishing Company

Access to resources Recommend Favorite

Peripheral metabotropic glutamate receptors as drug targets for pain relief

By Carlton Susan M   Neugebauer Volker  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 349-361

Informa Healthcare

Access to resources Recommend Favorite

Endocannabinoids New Targets for Drug Development

By  

Current Pharmaceutical Design, Vol. 6, Iss. 13, 2000-09 ,pp. : 1361-1380

Bentham Science Publishers

Access to resources Recommend Favorite

Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 17, 2011-09 ,pp. : 2192-2209

Bentham Science Publishers

Access to resources Recommend Favorite